Document

0001678531-17-000102.txt : 20170418 0001678531-17-000102.hdr.sgml : 20170418 20170418172211 ACCESSION NUMBER: 0001678531-17-000102 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20170418 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170418 DATE AS OF CHANGE: 20170418 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Envision Healthcare Corp CENTRAL INDEX KEY: 0001678531 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37955 FILM NUMBER: 17767644 BUSINESS ADDRESS: STREET 1: 1A BURTON HILLS BOULEVARD CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615-665-1283 MAIL ADDRESS: STREET 1: 1A BURTON HILLS BOULEVARD CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: New Amethyst Corp. DATE OF NAME CHANGE: 20160629 8-K 1 evhc8-k41817.htm 8-K Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 18, 2017 (April 18, 2017)

ENVISION HEALTHCARE CORPORATION

(Exact Name of Registrant as Specified in its Charter)



Delaware	001-37955	62-1493316
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1A Burton Hills Boulevard
Nashville, Tennessee		37215
(Address of Principal Executive Offices)		(Zip Code)

(615) 665-1283

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01. Regulation FD Disclosure

On October 4, 2016, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits:



99		Press release dated April 18, 2017

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



		Envision Healthcare Corporation



	By:	/s/ Claire M. Gulmi
		Claire M. Gulmi

		Executive Vice President and Chief Financial Officer
		(Principal Financial and Duly Authorized Officer)

Date: April 18, 2017

INDEX TO EXHIBITS



Exhibit
Number		Description
99		Press release dated April 18, 2017

EX-99 2 evhcex9941817.htm EXHIBIT 99 Exhibit

Exhibit 99



Contact:	Envision Healthcare Corporation
	Bob Kneeley
	Vice President, Investor Relations
	303-495-1245
	Bob.kneeley@evhc.net

ENVISION HEALTHCARE SETS EARNINGS RELEASE AND CONFERENCE CALL DATES FOR FIRST-QUARTER 2017 RESULTS

NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo. (April 18, 2017) - Envision Healthcare Corporation (NYSE: EVHC) today announced it will release its first-quarter 2017 financial results on Tuesday, May 2, 2017, after the market closes. The company will also host a conference call at 5:00 p.m. Eastern Time that same day. The live broadcast of Envision’s quarterly conference call will be available on-line by going to www.evhc.net and clicking on the link to Investors. The on-line replay will follow shortly after the call and continue for 30 days.

About Envision Healthcare Corporation

Envision Healthcare Corporation is a leading provider of physician-led services, ambulatory surgery services, post-acute care and medical transportation. Physician‑led services encompass providers at more than 780 hospitals in 45 states and the District of Columbia and include leadership positions in emergency department and hospitalist services, anesthesiology, radiology, and women’s and children’s services, as well as offerings in general surgery and office-based medicine. As a market leader in ambulatory surgical care, the company owns and operates 260 surgery centers and one surgical hospital in 35 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopedics. Post-acute care is delivered through an array of clinical professionals and integrated technologies designed to contribute to efficient and effective population health management strategies. As a leader in healthcare transportation services, the Company operates in 38 states and the District of Columbia. In total, the Company offers a differentiated suite of clinical solutions, creating value for health systems, payors, providers and patients. For additional information, visit www.evhc.net.

-END-

GRAPHIC 3 evhclogo20161201a02.jpg begin 644 evhclogo20161201a02.jpg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end